Quoted securities:

91,232,785 fully paid ordinary shares

ASX code: 

IBX

Time: 

10:30am, AEST

Date:

Thursday 22 June 2017

ASX Trade abbreviation: 

IMAGIONBIO

ISIN: 

AU000000IBX6

Home branch: 

Melbourne

Industry classification: 

3520 - Biotechnology

Registered office: 

C/-Holding Redlich

Level 8, 555 Bourke Street

Melbourne VIC 3000

Corporate Office:

C/- Imagion Biosystems Ltd
800 Bradbury Drive SE # 213
Albuquerque, New Mexico
87106,USA

Phone: +1 505-243-1058

Website: imagionbiosystems.com

Company secretary: 

Jovanka Naumoska

Share registry:

Boardroom Pty Ltd (NSW)

Balance date:

31 December

CHESS: 

Participating. The Company will also operate an issuer sponsored sub-register.

Place of incorporation:

Victoria

Dividend policy:

Refer to section 1.4 of the Company’s Prospectus.

Activities:

Research and development of medical diagnostics, specifically, medical imaging technology.

ASX Restricted securities: 

78,099,476 fully paid ordinary shares, classified by ASX as restricted securities to be held in escrow for a period of 24 months from the date of official quotation.

30,950,569 fully paid ordinary shares, classified by ASX as restricted securities to be held in escrow for a period of 12 months from the date of issue being 7 February 2017.

3,783,333 fully paid ordinary shares, classified by ASX as restricted securities to be held in escrow for a period of 12 months from the date of issue being 15 June 2017.

9,600,000 performance rights, classified by ASX as restricted securities to be held in escrow for a period of 24 months from the date of official quotation.

Securities not quoted: 

3,400,000 performance rights issued under the Company’s Long Term Incentive Plan.